Skip to content
Nonprofiteer
← FOUNDATION FIGHTING BLINDNESS INC

Form 990 for tax year 2022

Filed by FOUNDATION FIGHTING BLINDNESS INC.

Totals

Total revenue
$30,437,892
Total expenses
$51,265,440
Contributions and grants received
$28,901,504
Grants paid
$27,872,429
Program service revenue
$457,678
Investment income
$1,346,765
Other revenue
-$268,055
Total assets, end of year
$130,891,355
Total liabilities, end of year
$30,670,536
Net assets or fund balances, end of year
$100,220,819
Program services expenses (Part IX)
$41,374,660
Management and general expenses
$2,864,062
Fundraising expenses
$7,026,718
Program service expenses (Part III)
$41,374,660

Program services were 80.7% of total expenses calculated — Part IX's program-services column over total expenses, both as filed.

Line items

Every line the filer filed in Parts VIII, IX and X, as filed and in filed order. Blank columns are left out, and the lines are not forced to add up to the totals above.

Revenue

Part VIII, the statement of revenue.

  • 1a · Federated campaigns

    $150,166

  • 1c · Fundraising events

    $6,643,082

  • 1d · Related organizations

    $400,000

  • 1e · Government grants (contributions)

    $469,439

  • 1f · All other contributions, gifts and grants

    $21,238,817

  • 1g · Noncash contributions included above

    $7,511,241

  • 2a · Program service revenue: CONTRACT REVENUE

    total $395,548 · related or exempt $395,548

  • 2b · Program service revenue: PROGRAM FEES

    total $62,130 · related or exempt $62,130

  • 3 · Investment income

    total $3,426,537 · excluded $3,426,537

  • 5 · Royalties

    total $63,569 · excluded $63,569

  • 6a · Gross rents

    real property $29,767

  • 6b · Less rental expenses

    real property $0

  • 6c · Rental income or loss

    real property $29,767

  • 6d · Net rental income or loss

    total $29,767 · excluded $29,767

  • 7a · Gross sales of assets other than inventory

    securities $85,421,835

  • 7b · Less cost or other basis and sales expenses

    securities $87,501,607

  • 7c · Gain or loss

    securities -$2,079,772

  • 7d · Net gain or loss

    total -$2,079,772 · excluded -$2,079,772

  • 8a · Fundraising events: gross income

    $919,261

  • 8a · Fundraising events: contributions included on line 1c

    $6,643,082

  • 8b · Fundraising events: direct expenses

    $1,280,840

  • 8c · Net income from fundraising events

    total -$361,579 · excluded -$361,579

  • 10a · Gross sales of inventory

    $3,745

  • 10b · Cost of goods sold

    $3,633

  • 10c · Net income from sales of inventory

    total $112 · unrelated business $112

  • 11a · Other revenue: OTHER INCOME

    total $76 · excluded $76

  • 11e · Other revenue, total

    $76

Functional expenses

Part IX, the statement of functional expenses.

  • 1 · Grants to domestic organizations and governments

    total $24,421,364 · program services $24,421,364

  • 3 · Grants to foreign organizations and individuals

    total $3,451,065 · program services $3,451,065

  • 5 · Compensation of officers, directors and key employees

    total $2,486,009 · program services $1,233,642 · management and general $548,870 · fundraising $703,497

  • 7 · Other salaries and wages

    total $4,864,908 · program services $1,499,518 · management and general $705,719 · fundraising $2,659,671

  • 8 · Pension plan contributions

    total $319,399 · program services $113,708 · management and general $54,951 · fundraising $150,740

  • 9 · Other employee benefits

    total $773,911 · program services $281,723 · management and general $101,058 · fundraising $391,130

  • 10 · Payroll taxes

    total $510,095 · program services $182,939 · management and general $84,054 · fundraising $243,102

  • 11a · Fees: management

    total $1,720,285 · program services $1,297,548 · management and general $212,072 · fundraising $210,665

  • 11b · Fees: legal

    total $40,836 · program services $4,158 · management and general $36,678

  • 11c · Fees: accounting

    total $65,695 · management and general $59,668 · fundraising $6,027

  • 11d · Fees: lobbying

    total $260,000 · program services $200,000 · fundraising $60,000

  • 11e · Fees: professional fundraising services

    total $605,928 · fundraising $605,928

  • 11f · Fees: investment management

    total $257,252 · management and general $233,623 · fundraising $23,629

  • 12 · Advertising and promotion

    total $380,117 · program services $197,229 · fundraising $182,888

  • 13 · Office expenses

    total $404,212 · program services $106,924 · management and general $66,215 · fundraising $231,073

  • 14 · Information technology

    total $493,460 · program services $25,161 · management and general $118,204 · fundraising $350,095

  • 16 · Occupancy

    total $146,857 · program services $31,967 · management and general $65,737 · fundraising $49,153

  • 17 · Travel

    total $431,825 · program services $176,558 · management and general $80,024 · fundraising $175,243

  • 19 · Conferences, conventions and meetings

    total $1,428,257 · program services $756,068 · management and general $286,471 · fundraising $385,718

  • 22 · Depreciation, depletion and amortization

    total $112,060 · program services $87,482 · management and general $2,723 · fundraising $21,855

  • 23 · Insurance

    total $207,391 · program services $111,170 · management and general $21,934 · fundraising $74,287

  • 24a · Other expenses: TRIAL RELATED COSTS

    total $7,063,325 · program services $7,063,325

  • 24b · Other expenses: PROF FUNDRAISING-OTHER

    total $302,369 · fundraising $302,369

  • 24c · Other expenses: PRINTING & PRODUCTION

    total $252,055 · program services $133,111 · management and general $29,127 · fundraising $89,817

  • 24e · All other expenses

    total $266,765 · management and general $156,934 · fundraising $109,831

Balance sheet

Part X, book values.

  • 1 · Cash, non-interest-bearing

    beginning of year $1,176,123 · end of year $4,523,190

  • 2 · Savings and temporary cash investments

    beginning of year $11,369,807 · end of year $3,113,386

  • 3 · Pledges and grants receivable

    beginning of year $23,016,606 · end of year $19,463,729

  • 4 · Accounts receivable

    beginning of year $508,713 · end of year $541,936

  • 8 · Inventories for sale or use

    beginning of year $14,144 · end of year $16,821

  • 9 · Prepaid expenses and deferred charges

    beginning of year $567,589 · end of year $774,207

  • 10a · Land, buildings and equipment: cost or other basis

    $4,585,834

  • 10b · Land, buildings and equipment: accumulated depreciation

    $3,914,834

  • 10c · Land, buildings and equipment, net

    beginning of year $723,640 · end of year $671,000

  • 11 · Investments: publicly traded securities

    beginning of year $100,553,457 · end of year $93,775,426

  • 15 · Other assets

    beginning of year $7,947,775 · end of year $8,011,660

  • 17 · Accounts payable and accrued expenses

    beginning of year $1,790,153 · end of year $1,993,845

  • 18 · Grants payable

    beginning of year $15,215,025 · end of year $20,414,511

  • 19 · Deferred revenue

    beginning of year $210,498 · end of year $442,676

  • 25 · Other liabilities

    beginning of year $7,199,851 · end of year $7,819,504

  • 27 · Net assets without donor restrictions

    beginning of year $27,462,127 · end of year $19,019,760

  • 28 · Net assets with donor restrictions

    beginning of year $94,000,200 · end of year $81,201,059

Mission and programs · 2022

Mission

THE MISSION OF THE FOUNDATION FIGHTING BLINDNESS, INC. (FOUNDATION) IS TO DRIVE THE RESEARCH THAT WILL PROVIDE PREVENTIONS, TREATMENTS AND CURES, FOR PEOPLE AFFECTED BY RETINITIS PIGMENTOSA, MACULAR DEGENERATION, USHER SYNDROME, AND THE SPECTRUM OF RETINAL DEGENERATIVE DISEASES.

Activities or mission (Part I)

THE URGENT MISSION OF THE FOUNDATION FIGHTING BLINDNESS IS TO DRIVE THE RESEARCH THAT WILL PROVIDE PREVENTIONS, TREATMENTS AND CURES FOR PEOPLE AFFECTED BY RETINITIS PIGMENTOSA, AGE-RELATED MACULAR DEGENERATION, USHER SYNDROME AND THE ENTIRE SPECTRUM OF RETINAL DEGENERATIVE DISEASES. THE FOUNDATION IS A BEACON FOR THOSE AFFECTED BY THESE BLINDING DISEASES.

  • RESEARCH: THE FOUNDATION FIGHTING BLINDNESS, INC. (THE FOUNDATION) FUNDED RESEARCHERS ARE ACHIEVING REMARKABLE SUCCESS IN DISCOVERING, TESTING AND DELIVERING TO PATIENTS A WIDE RANGE OF PROMISING THERAPIES TO PREVENT, STOP THE PROGRESSION OF, AND CURE BLINDNESS DUE TO RETINAL DEGENERATIVE DISEASES. THE FOUNDATION HAS ENCUMBRANCES OF $50 MILLION, NOT INCLUDED ON OUR JUNE 30 FINANCIAL REPORT, FOR ACTIVE RESEARCH PROJECTS THAT HAVE FUTURE RESEARCH MILESTONES. OUR RESEARCH OVERSIGHT COMMITTEE'S SPENDING PLAN INCLUDES SPENDING AT AN AVERAGE OF $21 MILLION ANNUALLY TO SUPPORT FUTURE RESEARCH.AS OF THE END OF OUR FISCAL YEAR 2023, THE FOUNDATION'S RESEARCH GRANTS PROGRAM IS FUNDING 93 GRANTS BEING CONDUCTED BY MORE THAN 96 INVESTIGATORS AT 71 INSTITUTIONS, EYE HOSPITALS AND UNIVERSITIES IN THE U.S. AND AROUND THE WORLD. A SAMPLING OF THE RESEARCH PROJECTS FUNDED ARE LISTED BELOW."EVALUATING MITIGATION STRATEGIES FOR INTRAVITREAL VIRAL VECTOR-MEDIATED INFLAMMATION ACROSS ANIMAL MODELS."KATHRYN PEPPLE, MD, PHD, UNIVERSITY OF WASHINGTONDR. PEPPLE IS INVESTIGATING NOVEL STRATEGIES FOR MITIGATING OCULAR INFLAMMATION WHICH CAN RESULT FROM INTRAVITREAL INJECTION OF VIRAL GENE THERAPIES. SHE IS EVALUATING ANIMAL MODEL DATA AND PERFORMING DETAILED IMMUNOLOGIC CHARACTERIZATION OF THE NON-HUMAN PRIMATE EYES DURING OCULAR INFLAMMATION TO PROVIDE CLINICAL-PATHOLOGIC CORRELATIONS AND BIOMARKER VALIDATION FOR USE IN HUMAN CLINICAL STUDIES. A ROBUST AND EVIDENCE-BASED APPROACH TO PREVENTING OCULAR INFLAMMATION FOLLOWING INTRAVITREAL ADENO-ASSOCIATED VIRUS (AAV)-MEDIATED GENE THERAPY IS A CRITICAL UNMET NEED."A NOVEL, RATIONALLY DESIGNED PHARMACOLOGICAL APPROACH TO COUNTERING VISION LOSS IN A PRECLINICAL MODEL OF MERTK-ASSOCIATED RETINITIS PIGMENTOSA."SILVIA FINNEMANN, PHD, FORDHAM UNIVERSITYDR. FINNEMANN AND HER TEAM ARE DETERMINING IF AN EARLY-ONSET INFLAMMATORY RESPONSE IN RETINAL PIGMENT EPITHELIAL (RPE) CELLS PRECEDES PHOTORECEPTOR DEGENERATION. RPE CELLS PROVIDE PROVIDE CRITICAL SUPPORT FOR PHOTORECEPTORS. IF SUCCESSFUL IN UNCOVERING THIS NOVEL DISEASE PATHWAY, A THERAPEUTIC STRATEGY TESTING ANTI-INFLAMMATORY DRUGS FOR MERTK-ASSOCIATED RETINITIS PIGMENTOSA WILL BE PROPOSED TO PREVENT OR SIGNIFICANTLY DELAY RETINAL DEGENERATION."DECIPHERING THE IMPACT OF ABCA4 GENETIC VARIANTS OF UNKNOWN SIGNIFICANCE IN INHERITED RETINAL DISEASE PROGNOSIS."ESTHER BISWAS-FISS, MS, PHD, UNIVERSITY OF DELAWAREDR. BISWAS-FISS IS USING COMPUTATIONAL MODELING AND EXPERIMENTS TO DETERMINE WHETHER ABCA4 VARIANTS OF UNKNOWN SIGNIFICANCE (VUSS) LEAD TO ABCA4-RELATED DISEASE. RESOLVING THESE VUSS IS CRITICAL FOR PATIENTS TO MEET INCLUSION CRITERIA IN CLINICAL TRIALS FOR ABCA4 THERAPIES. MUTATIONS IN ABCA4 CAUSE THE VAST MAJORITY OF STARGARDT DISEASE CASES.

    Expenses $35,798,068 · Grants $27,872,429 · Revenue $457,678

  • PUBLIC HEALTH EDUCATION:DURING FISCAL YEAR 2023, THROUGH OUR CHATLOS FOUNDATION PUBLIC EDUCATION PROGRAM, THE FOUNDATION AIMED TO CONTINUE TO PROVIDE EDUCATION AND SUPPORT TO PEOPLE AFFECTED BY RETINAL DEGENERATIVE DISEASES. THE FOUNDATION ALSO FIELDS A TEAM OF PROFESSIONALS FOCUSED ON EDUCATING OPHTHALMOLOGISTS AND OPTOMETRISTS ON THE LATEST ADVANCEMENTS WITH THE FOUNDATIONS RESOURCES AND RESEARCH ON THE INHERITED RETINAL DISEASE SPACE. TO KEEP OUR CONSTITUENTS AND PROFESSIONALS INFORMED, THE FOUNDATION PUBLISHES EXTENSIVE CONTENT VIA WEBSITE AND SOCIAL MEDIA/EMAIL CHANNELS; DISTRIBUTES A NEWSLETTER ONLINE AND IN PRINT; HOLDS QUARTERLY INSIGHTS FORUM CALLS TO INFORM THE COMMUNITY ABOUT SCIENTIFIC PROGRESS. THE CONTENT PRODUCED INCLUDES THE LATEST DEVELOPMENTS IN RESEARCH AND CLINICAL TRIALS, AND PERSONAL STORIES FROM MEMBERS OF THE FIGHTING BLINDNESS COMMUNITY. ADDITIONALLY, THE FOUNDATION HOLDS CONTINUING MEDICAL EDUCATION COURSES TWICE A YEAR, FOCUSED ON PROVIDING TIMELY CONTENT TO EYECARE PROFESSIONALS. CHAPTERS BRING THE FOUNDATION'S MESSAGE AND MISSION TO LIFE. IN FY23 THE FOUNDATION SUPPORTED OVER 45 VOLUNTEER-LED CHAPTERS IN 23 STATES. THE CHAPTERS HELD 80 IN-PERSON SPEAKER PRESENTATIONS, SOCIALS, AND OTHER OUTREACH ACTIVITIES, HOSTED 4 VISION SEMINARS, AND CO-HOSTED TWO VIRTUAL VISION WEBINARS WITH THE FOUNDATION WITH OVER 1,000 PEOPLE IN ATTENDANCE FOR EACH WEBINAR. THIS YEAR, THE CHAPTERS ARE HOSTING NEARLY 90 IN-PERSON SPEAKER PRESENTATIONS AND LAUNCHING SEVERAL NEW CHAPTERS IN NEW STATES.

    Expenses $2,782,316

  • MY RETINA TRACKER REGISTRY:THE FOUNDATION MAINTAINS A RESEARCH DATABASE OF PEOPLE AND FAMILIES AFFECTED BY RARE INHERITED RETINAL DEGENERATIVE DISEASES. THE REGISTRY IS DESIGNED TO SHARE DE-IDENTIFIED INFORMATION WITHIN THE IRD RESEARCH AND CLINICAL COMMUNITIES ABOUT PEOPLE WITH AN INHERITED RETINAL DISEASE TO HELP ACCELERATE THE DISCOVERY OF TREATMENTS AND CURES. DURING FISCAL YEAR 2023 APPROXIMATELY 3,344 ADDITIONAL MEMBERS WERE ADDED TO THE REGISTRY, BRINGING TOTAL REGISTERED INDIVIDUALS UP TO 25,160.

    Expenses $2,794,276

As filed on the 2022 return. The filer continues this part on Schedule O, which is not shown here.

Listed in Part VII

  • DAVID BRINT

    CHAIRMAN OF THE BOARD

    Total calculated
    $0
    Hours/week
    10 + 1 related

  • EDWARD RUSSNOW

    VICE CHAIR, DEVELOPMENT

    Total calculated
    $0
    Hours/week
    1

  • JONATHAN STEINBERG MD

    VICE CHAIR, RESEARCH

    Total calculated
    $0
    Hours/week
    1 + 1 related

  • KAREN PETROU

    VICE CHAIR, AT LARGE

    Total calculated
    $0
    Hours/week
    1

  • MARYROSE SYLVESTER

    VICE CHAIR, AT LARGE

    Total calculated
    $0
    Hours/week
    1

  • STEVEN ALPER

    INTERIM VICE CHAIR, DEVELOPMENT

    Total calculated
    $0
    Hours/week
    1

  • JASON MORRIS

    VICE CHAIR, BOARD COMM & DEVELOPMENT AND TREASURER

    Total calculated
    $0
    Hours/week
    1

  • BRADFORD MANNING

    VICE CHAIR, MARKETING, COMM & SOCIAL MEDIA

    Total calculated
    $0
    Hours/week
    1

  • HAYNES LEA

    SECRETARY

    Total calculated
    $0
    Hours/week
    1

  • GORDON GUND

    DIRECTOR - CHAIRMAN EMERITUS

    Total calculated
    $0
    Hours/week
    1

  • SCOTT BURT

    DIRECTOR

    Total calculated
    $0
    Hours/week
    1

  • WILLIAM CARTY

    DIRECTOR

    Total calculated
    $0
    Hours/week
    1

  • YVONNE CHESTER

    DIRECTOR

    Total calculated
    $0
    Hours/week
    1

  • JOEL DAVIS

    DIRECTOR

    Total calculated
    $0
    Hours/week
    1

  • DARREN DEVOUE

    DIRECTOR

    Total calculated
    $0
    Hours/week
    1

  • JASON FERREIRA

    DIRECTOR

    Total calculated
    $0
    Hours/week
    1

  • ROBERT FINZI

    DIRECTOR

    Total calculated
    $0
    Hours/week
    1

  • JEFFREY FREED

    DIRECTOR

    Total calculated
    $0
    Hours/week
    1

  • ADRIENNE GRAVES PH D

    DIRECTOR

    Total calculated
    $0
    Hours/week
    1 + 1 related

  • ROBERT HEIDENBERG

    DIRECTOR

    Total calculated
    $0
    Hours/week
    1

  • JANICE LEHRER-STEIN

    DIRECTOR

    Total calculated
    $0
    Hours/week
    1

  • MARSHA LINK PHD

    DIRECTOR

    Total calculated
    $0
    Hours/week
    1

  • LAURA MANFRE

    DIRECTOR

    Total calculated
    $0
    Hours/week
    1

  • EVAN MITTMAN

    DIRECTOR

    Total calculated
    $0
    Hours/week
    1

  • DAVID NIXON

    DIRECTOR

    Total calculated
    $0
    Hours/week
    1

  • WARREN THALER

    DIRECTOR

    Total calculated
    $0
    Hours/week
    1 + 1 related

  • BENJAMIN R YERXA

    CEO (THRU 7/1/22)

    Total calculated
    $622,172
    From this org
    $248,524
    From related orgs
    $331,190
    Other
    $42,458
    Hours/week
    26 + 14 related

    Schedule J breakdown matched by us

    Base
    $188,641 + $298,945 related
    Bonus
    $59,520 + $32,049 related
    Other
    $363 + $196 related
    Deferred
    $2,860 + $1,540 related
    Nontaxable benefits
    $15,633 + $22,425 related
    Filer's total
    $267,017 + $355,155 related

  • JASON D MENZO

    CEO (BEG 7/1/22)

    Total calculated
    $523,027
    From this org
    $367,118
    From related orgs
    $91,780
    Other
    $64,129
    Hours/week
    32 + 8 related

    Schedule J breakdown matched by us

    Base
    $319,304 + $79,826 related
    Bonus
    $47,514 + $11,879 related
    Other
    $300 + $75 related
    Deferred
    $14,312 + $3,578 related
    Nontaxable benefits
    $36,991 + $9,248 related
    Filer's total
    $418,421 + $104,606 related

  • RICHELE DONAT

    CHRO

    Total calculated
    $289,907
    From this org
    $261,155
    From related orgs
    $0
    Other
    $28,752
    Hours/week
    40

    Schedule J breakdown matched by us

    Base
    $219,955
    Bonus
    $18,287
    Other
    $22,913
    Deferred
    $12,670
    Nontaxable benefits
    $16,082
    Filer's total
    $289,907

  • PETER GINSBERG

    COO

    Total calculated
    $389,133
    From this org
    $264,095
    From related orgs
    $66,023
    Other
    $59,015
    Hours/week
    32 + 8 related

    Schedule J breakdown matched by us

    Base
    $235,553 + $58,888 related
    Bonus
    $27,682 + $6,920 related
    Other
    $860 + $215 related
    Deferred
    $13,588 + $3,397 related
    Nontaxable benefits
    $33,624 + $8,406 related
    Filer's total
    $311,307 + $77,826 related

  • CLAIRE GELFMAN

    CHIEF SCIENTIFIC OFFICER

    Total calculated
    $419,861
    From this org
    $363,370
    From related orgs
    $0
    Other
    $56,491
    Hours/week
    40

    Schedule J breakdown matched by us

    Base
    $324,295
    Bonus
    $37,425
    Other
    $1,650
    Deferred
    $11,157
    Nontaxable benefits
    $45,334
    Filer's total
    $419,861

  • JUDY L TAYLOR

    SVP, CHIEF DEVELOPMENT OFFICER

    Total calculated
    $252,310
    From this org
    $198,073
    From related orgs
    $0
    Other
    $54,237
    Hours/week
    40

    Schedule J breakdown matched by us

    Base
    $182,659
    Bonus
    $14,656
    Other
    $758
    Deferred
    $12,350
    Nontaxable benefits
    $41,887
    Filer's total
    $252,310

  • MICHELE C DIVINCENZO

    VP, EVENTS

    Total calculated
    $221,441
    From this org
    $185,979
    From related orgs
    $0
    Other
    $35,462
    Hours/week
    40

    Schedule J breakdown matched by us

    Base
    $168,280
    Bonus
    $17,345
    Other
    $354
    Deferred
    $10,363
    Nontaxable benefits
    $25,099
    Filer's total
    $221,441

  • RUSSELL W KELLEY

    MANAGING DIRECTOR, RD FUND

    Total calculated
    $339,833
    From this org
    $0
    From related orgs
    $280,543
    Other
    $59,290
    Hours/week
    0 + 40 related

    Schedule J breakdown matched by us

    Base
    $0 + $260,777 related
    Bonus
    $0 + $19,209 related
    Other
    $0 + $557 related
    Deferred
    $0 + $16,971 related
    Nontaxable benefits
    $0 + $42,319 related
    Filer's total
    $0 + $339,833 related

  • TODD A DURHAM

    VP, CLINICAL & OUTCOMES RESEARCH

    Total calculated
    $279,761
    From this org
    $246,371
    From related orgs
    $0
    Other
    $33,390
    Hours/week
    40

    Schedule J breakdown matched by us

    Base
    $228,493
    Bonus
    $17,352
    Other
    $526
    Deferred
    $7,495
    Nontaxable benefits
    $25,895
    Filer's total
    $279,761

  • CHRISTOPHER S ADAMS

    VP, COMMUNICATIONS & MARKETING

    Total calculated
    $228,535
    From this org
    $182,079
    From related orgs
    $0
    Other
    $46,456
    Hours/week
    40

    Schedule J breakdown matched by us

    Base
    $164,307
    Bonus
    $17,412
    Other
    $360
    Deferred
    $1,883
    Nontaxable benefits
    $44,573
    Filer's total
    $228,535

  • AMY M PALMER LASTER

    SVP, SCIENCE STRATEGY & AWARDS

    Total calculated
    $211,697
    From this org
    $197,800
    From related orgs
    $0
    Other
    $13,897
    Hours/week
    40

    Schedule J breakdown matched by us

    Base
    $179,734
    Bonus
    $17,820
    Other
    $246
    Deferred
    $9,643
    Nontaxable benefits
    $4,254
    Filer's total
    $211,697

  • JEFFRY C COLLINS

    VP, DATABASE SYSTEMS & TECHNOLOGY

    Total calculated
    $214,944
    From this org
    $177,155
    From related orgs
    $0
    Other
    $37,789
    Hours/week
    40

    Schedule J breakdown matched by us

    Base
    $164,093
    Bonus
    $12,072
    Other
    $990
    Deferred
    $10,909
    Nontaxable benefits
    $26,880
    Filer's total
    $214,944

  • CHAD R JACKSON

    SR DIR, PRE-CLINICAL TRANSLATIONAL PROG

    Total calculated
    $195,704
    From this org
    $180,733
    From related orgs
    $0
    Other
    $14,971
    Hours/week
    40

    Schedule J breakdown matched by us

    Base
    $167,322
    Bonus
    $13,264
    Other
    $147
    Deferred
    $10,641
    Nontaxable benefits
    $4,330
    Filer's total
    $195,704

  • ANNA WAGNER

    VP, FINANCE

    Total calculated
    $178,910
    From this org
    $166,817
    From related orgs
    $0
    Other
    $12,093
    Hours/week
    40

    Schedule J breakdown matched by us

    Base
    $153,957
    Bonus
    $12,743
    Other
    $117
    Deferred
    $9,507
    Nontaxable benefits
    $2,586
    Filer's total
    $178,910

Compensation is as filed in Part VII: reportable pay from this organization and from related organizations, other compensation, and hours per week. The total, marked calculated, is our sum of the three dollar columns, with a blank column counted as $0; the form itself has no total. On a Form 990-EZ the columns are Part IV's instead, and on a Form 990-PF Part VIII's — compensation, contributions to benefit plans, and expense account — and the total sums those. A Schedule J breakdown is as filed: base pay, bonus, other, deferred compensation and nontaxable benefits from this organization, with any from related organizations beside each, and the filer's own total. It is shown with the Part VII listing of the same name on the same return. The form gives no key between the two, so that pairing is ours, and is marked matched by us.

Schedule J

Answered yes

  • 1a · Tax indemnification and gross-up payments
  • 1b · Written policy on the line-1a expenses
  • 2 · Substantiation required before reimbursing expenses
  • 3 · Compensation committee
  • 3 · Independent compensation consultant
  • 3 · Form 990 of other organizations
  • 3 · Compensation survey or study
  • 3 · Approval by the board or compensation committee
  • 7 · Other non-fixed payments

Answered no

  • 4a · Severance or change-of-control payment
  • 4b · Supplemental nonqualified retirement plan
  • 4c · Equity-based compensation arrangement
  • 5a · Pay contingent on this organization's revenues
  • 5b · Pay contingent on a related organization's revenues
  • 6a · Pay contingent on this organization's net earnings
  • 6b · Pay contingent on a related organization's net earnings
  • 8 · Paid under the initial-contract exception

The filer's explanations (Part III)

PART I, LINE 1A
SPOT BONUSES FOR EXTRAORDINARY WORK ARE PROVIDED TO EMPLOYEES. IF THE BONUS IS $1,000 OR LESS, IT IS GROSSED UP. THESE SPOT BONUSES AND GROSS UPS ARE INCLUDED IN TAXABLE COMPENSATION.
PART I, LINE 7
FFB EMPLOYEES PARTICIPATE IN AN ANNUAL INCENTIVE PLAN. THE PLAN PROVIDES AN ANNUAL CASH BONUS DEPENDING UPON THE ACHIEVEMENT OF PRE-DETERMINED ORGANIZATION AND INDIVIDUAL PERFORMANCE CRITERIA.

Part I's answers as filed. A line not listed was left unanswered; on lines 1a and 3 that means the box was not checked.

Grants on this return

The 10 largest by cash amount. The API serves every itemized grant.

Related organizations on this return

Schedule R Part II: tax-exempt organizations related to the filer by control. It does not record shared board members or money.

Taxable family on this return

Schedule R Parts I, III and IV, as filed. These record ownership and control, not shared board members or money moved.

Related corporations and trusts

Part IV: related organizations taxable as a corporation or trust.

  • OPUS GENETICS INC

    C · GENE THERAPY · DE · 6.35% owned · share of income $5,327 · share of assets $305,208 · controlled entity

    Directly controlled by FOUNDATION FIGHTING BLINDNESS INC

Provenance

Return type
form_990
Tax year
2022
Filed
1 November 2023
IRS schema version
2022v5.0
Source object
202333069349302708

Check it against the return as filed: the GivingTuesday Data Lake hosts a public copy of the original XML.

The source document this was parsed from is served over the API, which is where bulk and document access live.